Paula Ragan
Founder at X4 PHARMACEUTICALS, INC.
Net worth: 1 M $ as of 2024-03-30
Profile
Paula S.
Ragan was the founder of X4 Pharmaceuticals, Inc. (founded in 2014) and X4 Pharmaceuticals, Inc. (founded in 2010), where she holds the title of President, Chief Executive Officer & Director.
She is currently the Director at Camp4 Therapeutics Corp.
(since 2019).
Dr. Ragan has also held former positions as President, CEO, Secretary & Director at Arsanis, Inc., Senior Director-Corporate Development at Oscient Pharmaceuticals Corp., Principal at Pfizer Inc. and St. Lawrence Energy Corp., Head-Corporate Development & Operations at Genzyme Corp.
(from 2007 to 2012), and Principal at Celera Group.
Additionally, she served as the Chief Business Officer at Lysosomal Therapeutics, Inc. (from 2012 to 2014).
Dr. Ragan obtained a doctorate degree from Massachusetts Institute of Technology, an undergraduate degree from Tufts University, and another doctorate degree from Harvard Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
X4 PHARMACEUTICALS, INC.
0.46% | 2024-03-10 | 765,068 ( 0.46% ) | 1 M $ | 2024-03-30 |
Paula Ragan active positions
| Companies | Position | Start |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Founder | 2009-12-31 |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 2019-10-28 |
Former positions of Paula Ragan
| Companies | Position | End |
|---|---|---|
Lysosomal Therapeutics, Inc.
 Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lysosomal Therapeutics, Inc. engages in the innovation, research, and development in the field of neurodegeneration. It focuses in lysosomal biology in developing novel small molecules for use in the treatment of neurodegenerative diseases. The company was founded by Dimitri Krainc, Joseph Mazzulli, Henri A. Termeer, Robert J. Carpenter, Peter Wirth, Edmund J. Sybertz, and Kees Cornelis Been in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2014-08-31 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2012-07-31 |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Chief Executive Officer | - |
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Founder | - |
St. Lawrence Energy Corp.
 St. Lawrence Energy Corp. SemiconductorsElectronic Technology St. Lawrence Energy Corp. develops & markets advanced photo voltaic solar products. It focuses on the energy sector, including the development, sales and transportation of renewable energy products. The company's business plan is to enter & expand into the solar and related renewable energy. The company was founded in October 1990 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Training of Paula Ragan
| Massachusetts Institute of Technology | Doctorate Degree |
| Tufts University | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Commercial Services |
St. Lawrence Energy Corp.
St. Lawrence Energy Corp. SemiconductorsElectronic Technology St. Lawrence Energy Corp. develops & markets advanced photo voltaic solar products. It focuses on the energy sector, including the development, sales and transportation of renewable energy products. The company's business plan is to enter & expand into the solar and related renewable energy. The company was founded in October 1990 and is headquartered in Palo Alto, CA. | Electronic Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Health Technology |
X4 Pharmaceuticals, Inc. /Old/
X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology X4 Pharmaceuticals, Inc. develops novel therapeutics designed to improve immune cell trafficking to treat cancer and rare diseases. It offers X4P-001-RD, X4P-001-IO, and X4P-002. The company was founded by Paula Ragan, Alan Walts, Michael Gilman, Henri Termeer, Keith Flaherty, Renato Skerlj, and Richard Peters in July 2014 and is headquartered in Cambridge, MA. | Health Technology |
Celera Group
 Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Health Technology |
Lysosomal Therapeutics, Inc.
Lysosomal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lysosomal Therapeutics, Inc. engages in the innovation, research, and development in the field of neurodegeneration. It focuses in lysosomal biology in developing novel small molecules for use in the treatment of neurodegenerative diseases. The company was founded by Dimitri Krainc, Joseph Mazzulli, Henri A. Termeer, Robert J. Carpenter, Peter Wirth, Edmund J. Sybertz, and Kees Cornelis Been in 2011 and is headquartered in Cambridge, MA. | Health Technology |
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Paula Ragan
